BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Losurdo G, La Fortezza RF, Iannone A, Contaldo A, Barone M, Ierardi E, Di Leo A, Principi M. Prevalence and associated factors of obesity in inflammatory bowel disease: A case-control study. World J Gastroenterol 2020; 26(47): 7528-7537 [PMID: 33384552 DOI: 10.3748/wjg.v26.i47.7528] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Rivero-Gutiérrez B, Arredondo-Amador M, Gámez-Belmonte R, Sánchez de Medina F, Martínez-Augustin O. Leptin-resistant Zucker rats with trinitrobenzene sulfonic acid colitis present a reduced inflammatory response but enhanced epithelial damage. Am J Physiol Gastrointest Liver Physiol 2021;321:G157-70. [PMID: 34132111 DOI: 10.1152/ajpgi.00367.2020] [Reference Citation Analysis]
2 Khakoo NS, Ioannou S, Khakoo NS, Vedantam S, Pearlman M. Impact of Obesity on Inflammatory Bowel Disease. Curr Gastroenterol Rep 2022. [PMID: 35150406 DOI: 10.1007/s11894-022-00840-x] [Reference Citation Analysis]
3 Pan S, Hong F, Li L, Guo Y, Qiao X, Zhang J, Xu P, Zhai Y. Melatonin Attenuates Dextran Sodium Sulfate Induced Colitis in Obese Mice. Pharmaceuticals (Basel) 2021;14:822. [PMID: 34451919 DOI: 10.3390/ph14080822] [Reference Citation Analysis]
4 Rocha R, de J Santos G, Santana G. Influence of nutritional status in the postoperative period of patients with inflammatory bowel disease. World J Gastrointest Pharmacol Ther 2021; 12(5): 90-99 [PMID: 34616585 DOI: 10.4292/wjgpt.v12.i5.90] [Reference Citation Analysis]
5 Losurdo G, Brescia IV, Lillo C, Mezzapesa M, Barone M, Principi M, Ierardi E, Di Leo A, Rendina M. Liver involvement in inflammatory bowel disease: What should the clinician know? World J Hepatol 2021; 13(11): 1534-1551 [PMID: 34904028 DOI: 10.4254/wjh.v13.i11.1534] [Reference Citation Analysis]